Significant Contribution of Interleukin-18 Genotypes to Lung Cancer Risk in Taiwanese

Anticancer Res. 2022 Jul;42(7):3381-3387. doi: 10.21873/anticanres.15825.

Abstract

Background/aim: The elevated expression of interleukin-18 (IL-18) among lung cancer patients raised our curiosity to examine the role of IL-18 genotypes in lung cancer.

Materials and methods: IL-18 -656 (rs1946519), -607 (rs1946518), and -137 (rs187238) genotypes of 358 lung cancer cases and 716 controls were determined via the PCR-RFLP methodology.

Results: The distributions of genotypic and allelic frequencies of IL-18 -607, but not those of -656 or -137, were differentially distributed between cases and controls. IL-18 -607 AC and CC genotypes were both lower (45.8% and 16.2%) in lung cancer patients compared to controls (51.4% and 24.7%). In addition, IL-18 -607 AC and CC genotypes were of significantly lower percentages both among non-smokers and smokers. Otherwise, no differential distribution was found regarding IL-18 -656 or -137.

Conclusion: IL-18 -607 C allele can serve as a protective predictor for lung cancer risk in Taiwanese.

Keywords: Genotype; Taiwan; interleukin-18; lung cancer; polymorphism; smoking.

MeSH terms

  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Interleukin-18* / genetics
  • Lung Neoplasms* / genetics
  • Polymorphism, Single Nucleotide

Substances

  • Interleukin-18